Corrigendum to "The treatment of primary biliary cholangitis: from shadow to light"

DOI: https://doi.org/10.1177/17562848241277276

2024-08-31

Abstract:[This corrects the article DOI: 10.1177/17562848241265782.].

What problem does this paper attempt to address?

Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Lanlan Xiao,Xingqi Xu,Kaizhou Huang,Yalei Zhao,Lingjian Zhang,Lanjuan Li

DOI: https://doi.org/10.1155/2021/9875940

2021-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2019/3757149.].
Corrigendum to A Case of Grover's Disease Secondary to Brodalumab Therapy for Psoriasis

DOI: https://doi.org/10.1177/24755303231195863

Abstract:[This corrects the article DOI: 10.1177/2475530320970530.].
Corrigendum to Biologic Treatment of 4 HIV-Positive Patients: A Case Series and Literature Review

DOI: https://doi.org/10.1177/24755303231195885

Abstract:[This corrects the article DOI: 10.1177/2475530320954279.].
Corrigendum to Antibody Response to BNT162b2 Vaccine in Immune Modifiers-Treated Psoriatic Patients

DOI: https://doi.org/10.1177/24755303231195874

Abstract:[This corrects the article DOI: 10.1177/24755303211056059.].
Corrigendum to Tofacitinib for the Treatment of Refractory Palmoplantar Psoriasis: A Case Series

DOI: https://doi.org/10.1177/24755303231195857

Abstract:[This corrects the article DOI: 10.1177/2475530321995516.].
Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Hangying Ying,Hongdi Yuan,Xiaomei Tang,Wenpu Guo,Ruhong Jiang,Chenyang Jiang

DOI: https://doi.org/10.3389/fcvm.2021.723626

IF: 3.6

2021-01-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.641062.].
Corrigendum to Brodalumab for Treatment-Resistant Psoriasis: Case Reports and Safety Update

DOI: https://doi.org/10.1177/24755303231195864

Abstract:[This corrects the article DOI: 10.1177/2475530320925067.].
Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

DOI: https://doi.org/10.1177/17588359241290373

2024-10-21

Abstract:[This corrects the article DOI: 10.1177/17588359241267148.].
Corrigendum to "Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report."

DOI: https://doi.org/10.1177/20542704241260192

2024-06-02

JRSM Open

Abstract:[This corrects the article DOI: 10.1177/20542704221148059.].
Erratum: Sun C, Tian X, Lee YS, et al. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 2015;126(19):2213-2219

DOI: https://doi.org/10.1182/blood-2016-06-725010

IF: 20.3

2016-08-18

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2015-04-639203.].
Corrigendum: Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease

DOI: https://doi.org/10.14218/jcth.2022.00425

2022-09-30

Journal of Clinical and Translational Hepatology

Abstract:[This corrects the article DOI: 10.14218/JCTH.2021.00046.].

gastroenterology & hepatology
Corrigendum to Remission of Recalcitrant Psoriasis on Combined Biologic Therapy With Infliximab and Ustekinumab

DOI: https://doi.org/10.1177/24755303231195884

Abstract:[This corrects the article DOI: 10.1177/24755303211029598.].
Corrigendum to: A new therapy for Transthyretin amyloidosis, no longer an orphan condition

DOI: https://doi.org/10.1093/eurheartj/suab065

2021-07-18

Abstract:[This corrects the article DOI: 10.1093/eurheartjsupp/suaa077.][This corrects the article DOI: 10.1093/eurheartj/suaa077.].
Corrigendum to Successful Treatment of Guttate Psoriasis With Ixekizumab: A Case Series

DOI: https://doi.org/10.1177/24755303231195862

Abstract:[This corrects the article DOI: 10.1177/2475530320970538.].
Corrigendum to Practice Patterns of Palmoplantar Pustulosis: Patient Demographics and Treatment Options

DOI: https://doi.org/10.1177/24755303231195875

Abstract:[This corrects the article DOI: 10.1177/24755303221099292.].
Corrigendum To: Pathogenic Characteristics and Treatment in 43 Cases of Acute Colchicine Poisoning

Xiaofan Lu,Yanqing Liu,Chunyan Wang,Jianguang Dong,Lili Bai,Chengcheng Zhang,Renzheng Zhang,Chengwen Sun,Zewu Qiu

DOI: https://doi.org/10.1093/toxres/tfab089

2021-01-01

Toxicology Research

Abstract:[This corrects the article DOI: 10.1093/toxres/tfab074.].
Correction to "Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up"

DOI: https://doi.org/10.1002/hem3.118

2024-07-22

HemaSphere

Abstract:[This corrects the article DOI: 10.1002/hem3.89.].
Corrigendum to Treatment of Palmoplantar Pustulosis Using Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion: A Case Report

DOI: https://doi.org/10.1177/24755303231196711

Abstract:[This corrects the article DOI: 10.1177/2475530320950290.].
Corrigendum to “Antroquinonol Exerts Immunosuppressive Effect on CD8+ T Cell Proliferation and Activation to Resist Depigmentation Induced by H2O2”

Cuiping Guan,Qingtian Li,Xiuzu Song,Wen Xu,Liuyu Li,Aie Xu

DOI: https://doi.org/10.1155/2020/1402346

2020-10-19

Oxidative Medicine and Cellular Longevity

Abstract:[This corrects the article DOI: 10.1155/2017/9303054.].

cell biology
Corrigendum to “Exploring comorbidity and pharmacological treatment patterns in psoriasis - A retrospective population-based cross-sectional study”

DOI: https://doi.org/10.1177/26335565231223601

2023-12-01

Journal of Multimorbidity and Comorbidity

Abstract:[This corrects the article DOI: 10.1177/26335565231212336.].

Corrigendum to "The treatment of primary biliary cholangitis: from shadow to light"

Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Corrigendum to A Case of Grover's Disease Secondary to Brodalumab Therapy for Psoriasis

Corrigendum to Biologic Treatment of 4 HIV-Positive Patients: A Case Series and Literature Review

Corrigendum to Antibody Response to BNT162b2 Vaccine in Immune Modifiers-Treated Psoriatic Patients

Corrigendum to Tofacitinib for the Treatment of Refractory Palmoplantar Psoriasis: A Case Series

Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Corrigendum to Brodalumab for Treatment-Resistant Psoriasis: Case Reports and Safety Update

Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

Corrigendum to "Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report."

Erratum: Sun C, Tian X, Lee YS, et al. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 2015;126(19):2213-2219

Corrigendum: Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease

Corrigendum to Remission of Recalcitrant Psoriasis on Combined Biologic Therapy With Infliximab and Ustekinumab

Corrigendum to: A new therapy for Transthyretin amyloidosis, no longer an orphan condition

Corrigendum to Successful Treatment of Guttate Psoriasis With Ixekizumab: A Case Series

Corrigendum to Practice Patterns of Palmoplantar Pustulosis: Patient Demographics and Treatment Options

Corrigendum To: Pathogenic Characteristics and Treatment in 43 Cases of Acute Colchicine Poisoning

Correction to "Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up"

Corrigendum to Treatment of Palmoplantar Pustulosis Using Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion: A Case Report

Corrigendum to “Antroquinonol Exerts Immunosuppressive Effect on CD8+ T Cell Proliferation and Activation to Resist Depigmentation Induced by H2O2”

Corrigendum to “Exploring comorbidity and pharmacological treatment patterns in psoriasis - A retrospective population-based cross-sectional study”